Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Shares Issued (2024 - 2025)

Prelude Therapeutics (PRLD) has disclosed Shares Issued for 2 consecutive years, with -$76000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 61.03% to -$76000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$271000.0 through Dec 2025, down 551.67% year-over-year, with the annual reading at $16000.0 for FY2025, 73.33% down from the prior year.
  • Shares Issued hit -$76000.0 in Q4 2025 for Prelude Therapeutics, up from -$195000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $253000.0 in Q2 2024 to a low of -$195000.0 in Q4 2024.